Galera Therapeutics shareholders elect two Class I directors, ratify KPMG

Galera Therapeutics, Inc.

Michael Powell, Ph.D. elected with 15,141,283 votes for (76.2% of votes cast).
Linda West elected with 15,219,991 votes for (76.6% of votes cast); broker non-votes were 8,447,493.
KPMG LLP ratified as independent auditor for 2023 with 28,291,469 votes for, 9,547 against.
Turnout was 28,312,177 shares, representing 65.98% of outstanding common stock.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Galera Therapeutics, Inc. shareholders approved Election of two Class I Directors to serve until the 2026 Annual Meeting of Stockholders at the 2023-06-14 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-14

Exact text from the filing

Item 1 — Election of two Class I Directors to serve until the 2026 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified. NOMINEE Votes FOR Votes WITHHELD Broker Non-Votes Michael Powell, Ph.D. 15,141,283 4,723,401 8,447,493 Linda West 15,219,991 4,644,693 8,447,493

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Galera Therapeutics, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 at the 2023-06-14 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-14

Exact text from the filing

Item 2 — Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 28,291,469 9,547 11,161 0

View on SEC.gov

352 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Galera Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-167905

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.